Clinical Trials List
2025-11-01 - 2030-12-31
Phase III
Recruiting6
ICD-10N03.1
Chronic nephritic syndrome with focal and segmental glomerular lesions
ICD-10N03.3
Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
ICD-9582.1
Chronic glomerulonephritis, with lesion of membranous glomerulonephritis
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEN-CHIH CHIANG Division of General Internal Medicine
- 潘思宇 Division of Family Medicine
- 謝易庭 Division of Ophthalmology
- CHUN-FU LAI Division of General Internal Medicine
- 楊紹佑 Division of General Internal Medicine
- 黃道民 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TUNG-MIN YU Division of Nephrology
- 蔡尚峰 Division of Nephrology
- CHENG-HSU CHEN Division of Nephrology
- LIN-SHIEN Fu Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cai-Mei Zheng
- 賴史忠 Division of Ophthalmology
- YUNG-HO HSU
- Mei-Yi Wu
- Chia-Te Liao
- Li-Yee Hong
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
286 participants
